Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial-Reference-Cited by-同舟云学术

Combination of antihypertensive therapy in the elderly, multicenter investigation (CAMUI) trial

Published:2013-06 Issue:6 Volume:31 Page:1245-1255
ISSN:0263-6352
Container-title:Journal of Hypertension
language:en
Short-container-title:

Author:

Sato Nobuyuki,Saijo Yasuaki,Sasagawa Yutaka,Morimoto Hideo,Takeuchi Toshiharu,Sano Hiroaki,Koyama Satoshi,Takehara Naofumi,Morita Kazutoyo,Sumitomo Kazuhiro,Maruyama Junichi,Kikuchi Kenjiro,Hasebe Naoyuki

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine,Physiology,Internal Medicine

Reference38 articles.

1. Current status of antihypertensive prescription and associated blood pressure control in Japan.;Mori;Hypertens Res,2006

2. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2009).;Ogihara;Hypertens Res,2009

3. 2007 Guidelines for the Management of Arterial Hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).;Mancia;J Hypertens,2007

4. American Society of Hypertension Writing Group. Combination therapy in hypertension.;Gradman;J Am Soc Hypertens,2010

5. ACCOMPLISH Trial Investigators. Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.;Jamerson;N Engl J Med,2008

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Blood-Brain Barrier Crossing Renin-Angiotensin Drugs and Cognition in the Elderly: A Meta-Analysis;Hypertension;2021-09

2. Pharmacological treatment of hypertension in people without prior cerebrovascular disease for the prevention of cognitive impairment and dementia;Cochrane Database of Systematic Reviews;2021-05-24

3. Assessment of suitable antihypertensive therapies: Combination with high‐dose amlodipine/irbesartan vs triple combination with amlodipine/irbesartan/indapamide (ASAHI‐AI study);The Journal of Clinical Hypertension;2020-08-06

4. The benefits of angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers combined with calcium channel blockers on metabolic, renal, and cardiovascular outcomes in hypertensive patients: a meta-analysis;International Urology and Nephrology;2018-10-15

5. Pharmacologic Interventions to Prevent Cognitive Decline, Mild Cognitive Impairment, and Clinical Alzheimer-Type Dementia;Annals of Internal Medicine;2017-12-19